An endocrine health monitoring system based on medical atlas

Abstract

The present invention discloses an endocrine health monitoring system based on a medical atlas, which relates to the field of endocrine health and includes a monitoring center, wherein the monitoring center is communicatively connected with a data acquisition module, a medical atlas construction module, a data processing module, a data analysis module, a health assessment module and a prevention and treatment module; the body data of a monitored person is collected, an endocrine medical atlas is constructed according to the collected body data of the monitored person, the body data of the monitored person in the constructed endocrine medical atlas is processed to obtain a change line graph, the obtained change line graph is analyzed to obtain an analysis result, whether the endocrine of the monitored person is healthy is evaluated according to the analysis result to obtain an evaluation result, prevention and treatment are carried out on the monitored person according to the evaluation result, the monitored person is monitored in real time, and the accuracy of monitoring and the timeliness of prevention are further improved.

Description

Technical Field

[0001] The present invention relates to the field of endocrine health, and in particular to an endocrine health monitoring system based on medical atlas. Background Art

[0002] The endocrine system is an important system of the human body. It regulates metabolism, growth and development, emotions, sexual function and other physiological processes by secreting hormones. Endocrine disorders may lead to a variety of health problems, including diabetes, thyroid disease, obesity, osteoporosis, etc. Therefore, monitoring and managing endocrine health is crucial for the prevention and treatment of related diseases. With the improvement of people's health awareness and the advancement of science and technology, more and more people hope to actively manage their health, especially for patients with chronic diseases of the endocrine system. They need a convenient, efficient and personalized health management tool to help them monitor and manage their health on a daily basis. The endocrine health monitoring system based on medical maps came into being to meet this demand.

[0003] How to conduct real-time monitoring of the monitored persons, take corresponding drugs for treatment according to the monitoring results, predict the levels of various hormones in the bodies of the monitored persons, take corresponding preventive measures according to the predicted results, and further improve the accuracy of monitoring and the timeliness of prevention are the problems we need to solve. To this end, an endocrine health monitoring system based on medical atlas is now provided. Summary of the invention

[0004] In order to solve the above technical problems, the purpose of the present invention is to provide an endocrine health monitoring system based on medical atlas.

[0005] The object of the present invention can be achieved by the following technical solutions: an endocrine health monitoring system based on medical atlas, comprising a monitoring center, wherein the monitoring center is communicatively connected with a data acquisition module, a medical atlas construction module, a data processing module, a data analysis module, a health assessment module, and a prevention and treatment module;

[0006] The data acquisition module is used to collect physical data of the monitored person;

[0007] The medical atlas construction module is used to construct an endocrine medical atlas based on the collected physical data of the monitored person;

[0008] The data processing module is used to process the physical data of the monitored person in the constructed endocrine medical atlas to obtain a thyroid hormone change line graph, an adrenaline change line graph, and an endocrine hormone change line graph;

[0009] The data analysis module is used to analyze the obtained thyroid hormone change line graph, adrenaline change line graph and endocrine hormone change line graph to obtain analysis results;

[0010] The health assessment module is used to assess whether the endocrine system of the monitored person is healthy based on the analysis results to obtain the assessment results;

[0011] The prevention and treatment module is used to carry out prevention and treatment on the monitored person according to the evaluation results.

[0012] Furthermore, the process of the data collection module collecting the physical data of the monitored person includes:

[0013] The physical data of the monitored person includes the content of thyroid hormone, adrenaline and endocrine hormone in the body of the monitored person;

[0014] The data acquisition module is provided with a hormone data acquisition terminal, and the hormone data acquisition terminal is used to collect the content of thyroid hormone, adrenaline and endocrine hormone in the body of the monitored person;

[0015] The hormone data collection terminal is used to obtain the thyroid hormone content, adrenaline content and endocrine hormone content in the body of the monitored person.

[0016] Furthermore, the process of the medical map construction module constructing an endocrine medical map according to the collected physical data of the monitored person includes:

[0017] The endocrine medical atlas is composed of a thyroid hormone node, an adrenaline node, an endocrine hormone node, a thyroid hormone symptom node, an adrenaline symptom node, an endocrine hormone symptom node, a thyroid hormone drug node, an adrenaline drug node, and an endocrine hormone drug node;

[0018] Connect the corresponding nodes, obtain the symptoms and corresponding drugs caused by the content of thyroid hormone, adrenaline and endocrine hormone according to the medical data in the hospital, input the obtained symptoms caused by the content of thyroid hormone into the thyroid hormone symptom node, input the obtained drugs corresponding to the symptoms caused by the content of thyroid hormone into the thyroid hormone drug node, and so on, input the corresponding symptoms and drugs into the corresponding nodes;

[0019] The obtained thyroid hormone content, adrenaline content and endocrine hormone content in the body of the monitored person are input into the thyroid hormone node, adrenaline node and endocrine hormone node respectively.

[0020] Furthermore, the process of the data processing module processing the body data of the monitored person in the constructed endocrine medical atlas includes:

[0021] Constructing a two-dimensional rectangular coordinate system of the thyroid hormone content in the body of the monitored person in terms of time, mapping the acquired thyroid hormone content in the body of the monitored person to the constructed two-dimensional rectangular coordinate system of the thyroid hormone content in the body of the monitored person in terms of time, generating corresponding thyroid hormone data sample points, and connecting each thyroid hormone data sample point in sequence through a broken line in chronological order to obtain a broken line graph of thyroid hormone changes in the monitored person;

[0022] Constructing a two-dimensional rectangular coordinate system of the adrenaline content in the body of the monitored person in terms of time, mapping the acquired adrenaline content in the body of the monitored person to the constructed two-dimensional rectangular coordinate system of the adrenaline content in the body of the monitored person in terms of time, generating corresponding adrenaline data sample points, and connecting each adrenaline data sample point in time sequence through a broken line to obtain a broken line graph of adrenaline changes in the monitored person;

[0023] Construct a two-dimensional rectangular coordinate system of the content of endocrine hormones in the body of the monitored person in time, map the acquired content of endocrine hormones in the body of the monitored person to the constructed two-dimensional rectangular coordinate system of the content of endocrine hormones in the body of the monitored person in time, generate corresponding endocrine hormone data sample points, and connect each endocrine hormone data sample point in time sequence through a broken line to obtain a line graph of endocrine hormone changes of the monitored person.

[0024] Furthermore, the process of the data analysis module analyzing the obtained thyroid hormone change line graph, adrenaline change line graph and endocrine hormone change line graph includes:

[0025] Obtain the thyroid hormone content in the body of the monitored person corresponding to each thyroid hormone data sample point, and set the thyroid hormone content threshold range according to the actual situation. If the thyroid hormone content in the body of the monitored person corresponding to a thyroid hormone data sample point is not within the set thyroid hormone content threshold range, the thyroid hormone content in the body of the monitored person is abnormal; otherwise, the thyroid hormone content in the body of the monitored person is normal, and the previous thyroid hormone data sample point of the last thyroid hormone data sample point is recorded as the reference thyroid hormone data sample point, and the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point is compared with the thyroid hormone content in the body of the monitored person corresponding to the reference thyroid hormone data sample point;

[0026] Obtaining a high prediction coefficient or a low prediction coefficient of the last thyroid hormone data sample point according to the comparison result;

[0027] Predicting the thyroid hormone content in the body of the monitored person according to the obtained high prediction coefficient and low prediction coefficient, and obtaining a risk level if the thyroid hormone content in the body of the monitored person is not within the set thyroid hormone content threshold range, wherein the risk level includes a primary risk and a secondary risk;

[0028] The adrenaline content in the body of the monitored person corresponding to each adrenaline data sample point is obtained, and the adrenaline content threshold range is set according to the actual situation. If the adrenaline content in the body of the monitored person corresponding to the adrenaline data sample point is not within the set adrenaline content threshold range, the adrenaline content in the body of the monitored person is abnormal. Otherwise, the adrenaline content in the body of the monitored person is normal. The same method is used to obtain the risk level of the adrenaline content in the body of the monitored person that is not within the set adrenaline content threshold range. The risk level includes primary risk and secondary risk;

[0029] The endocrine hormone content in the body of the monitored person corresponding to each endocrine hormone data sample point is obtained, and the endocrine hormone content threshold range is set according to the actual situation. If the endocrine hormone content in the body of the monitored person corresponding to the endocrine hormone data sample point is not within the set endocrine hormone content threshold range, the endocrine hormone content in the body of the monitored person is abnormal. Otherwise, the endocrine hormone content in the body of the monitored person is normal. The same method is used to obtain the risk level of the endocrine hormone content in the body of the monitored person that is not within the set endocrine hormone content threshold range. The risk level includes primary risk and secondary risk.

[0030] Further, the process of obtaining the high prediction coefficient or the low prediction coefficient of the last thyroid hormone data sample point according to the comparison result includes:

[0031] If the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point is greater than or equal to the thyroid hormone content in the body of the monitored person corresponding to the reference thyroid hormone data sample point, the high prediction coefficient of the last thyroid hormone data sample point is obtained; if the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point is less than the thyroid hormone content in the body of the monitored person corresponding to the reference thyroid hormone data sample point, the low prediction coefficient of the last thyroid hormone data sample point is obtained.

[0032] Furthermore, the process of the health assessment module assessing whether the endocrine system of the monitored person is healthy according to the analysis results includes:

[0033] When the levels of thyroid hormone, adrenaline and endocrine hormones in the monitored person's body are normal, the monitored person's endocrine system is healthy;

[0034] When the content of thyroid hormone, adrenaline or endocrine hormone in the body of the monitored person is abnormal, the endocrine of the monitored person is unhealthy;

[0035] When the thyroid hormone content in the monitored person's body is not within the set thyroid hormone content threshold range and the risk level is Level 2 risk, or the adrenaline content is not within the set adrenaline content threshold range and the risk level is Level 2 risk, or the endocrine hormone content is not within the set endocrine hormone content threshold range and the risk level is Level 2 risk, the monitored person's endocrine prediction is unhealthy.

[0036] Furthermore, the process of the prevention and treatment module performing prevention and treatment on the monitored person according to the evaluation results includes:

[0037] When the endocrine system of the monitored person is unhealthy, the corresponding symptoms and corresponding medicines are obtained according to the endocrine medical atlas, and the monitored person is treated with the obtained corresponding medicines;

[0038] When the endocrine prediction of the monitored person is unhealthy, the monitored person will be reminded to take corresponding preventive measures.

[0039] Compared with the prior art, the beneficial effects of the present invention are: collecting the physical data of the monitored person, constructing an endocrine medical atlas based on the collected physical data of the monitored person, processing the physical data of the monitored person in the constructed endocrine medical atlas, obtaining a change line graph, analyzing the obtained change line graph, obtaining an analysis result, evaluating whether the endocrine of the monitored person is healthy based on the analysis result, obtaining an evaluation result, preventing and treating the monitored person based on the evaluation result, monitoring the monitored person in real time, taking corresponding drugs for treatment based on the monitoring results, predicting the levels of various hormones in the body of the monitored person, taking corresponding preventive measures for prevention based on the prediction results, thereby further improving the accuracy of monitoring and the timeliness of prevention. BRIEF DESCRIPTION OF THE DRAWINGS

[0040] Figure 1 It is a schematic diagram of the present invention. DETAILED DESCRIPTION

[0041] like Figure 1As shown, an endocrine health monitoring system based on medical atlas includes a monitoring center, wherein the monitoring center is communicatively connected with a data acquisition module, a medical atlas construction module, a data processing module, a data analysis module, a health assessment module, and a prevention and treatment module;

[0042] The data acquisition module is used to collect physical data of the monitored person;

[0043] It should be further explained that, in the specific implementation process, the process of the data collection module collecting the body data of the monitored person includes:

[0044] The physical data of the monitored person includes the content of thyroid hormone, adrenaline and endocrine hormone in the body of the monitored person;

[0045] The endocrine hormones include luteinizing hormone, progesterone, follicle-stimulating hormone, etc.

[0046] The data acquisition module is provided with a hormone data acquisition terminal, and the hormone data acquisition terminal is used to collect the content of thyroid hormone, adrenaline and endocrine hormone in the body of the monitored person;

[0047] The hormone data collection terminal is used to obtain the thyroid hormone content, adrenaline content and endocrine hormone content in the body of the monitored person.

[0048] The medical atlas construction module is used to construct an endocrine medical atlas based on the collected physical data of the monitored person;

[0049] It should be further explained that, in the specific implementation process, the process of the medical map construction module constructing the endocrine medical map according to the collected physical data of the monitored person includes:

[0050] The endocrine medical atlas is composed of a thyroid hormone node, an adrenaline node, an endocrine hormone node, a thyroid hormone symptom node, an adrenaline symptom node, an endocrine hormone symptom node, a thyroid hormone drug node, an adrenaline drug node, and an endocrine hormone drug node;

[0051] Connect the thyroid hormone node with the thyroid hormone symptom node and the adrenaline node, connect the thyroid hormone symptom node with the thyroid hormone drug node, connect the adrenaline node with the adrenaline symptom node and the endocrine hormone node, connect the adrenaline symptom node with the adrenaline drug node, connect the endocrine hormone symptom node with the endocrine hormone symptom node, and connect the endocrine hormone symptom node with the endocrine hormone drug node;

[0052] According to the medical data in the hospital, the symptoms and corresponding drugs caused by the contents of thyroid hormone, adrenaline and endocrine hormone are obtained, and the obtained symptoms caused by the contents of thyroid hormone are input into the thyroid hormone symptom node, and the drugs corresponding to the symptoms caused by the contents of thyroid hormone are input into the thyroid hormone drug node, the obtained symptoms caused by the contents of adrenaline are input into the adrenaline symptom node, and the drugs corresponding to the symptoms caused by the contents of adrenaline are input into the adrenaline drug node, the obtained symptoms caused by the contents of endocrine hormones are input into the endocrine hormone symptom node, and the drugs corresponding to the symptoms caused by the contents of endocrine hormones are input into the endocrine hormone drug node;

[0053] The obtained thyroid hormone content, adrenaline content and endocrine hormone content in the body of the monitored person are input into the thyroid hormone node, adrenaline node and endocrine hormone node respectively.

[0054] The data processing module is used to process the physical data of the monitored person in the constructed endocrine medical atlas to obtain a thyroid hormone change line graph, an adrenaline change line graph, and an endocrine hormone change line graph;

[0055] It should be further explained that, in the specific implementation process, the process of the data processing module processing the body data of the monitored person in the constructed endocrine medical atlas includes:

[0056] Construct a two-dimensional rectangular coordinate system of the content of thyroid hormone in the body of the monitored person in time, map the obtained content of thyroid hormone in the body of the monitored person to the constructed two-dimensional rectangular coordinate system of the content of thyroid hormone in the body of the monitored person in time, generate corresponding thyroid hormone data sample points, label the generated thyroid hormone data sample points, record them as i, i=1, 2, 3, ..., n, n is a positive integer, and connect each thyroid hormone data sample point in time order through a broken line to obtain a line graph of thyroid hormone changes of the monitored person;

[0057] Constructing a two-dimensional rectangular coordinate system of the adrenaline content in the body of the monitored person in time, mapping the acquired adrenaline content in the body of the monitored person to the constructed two-dimensional rectangular coordinate system of the adrenaline content in the body of the monitored person in time, generating corresponding adrenaline data sample points, labeling the generated adrenaline data sample points, recording them as i, and connecting each adrenaline data sample point in time order through a broken line to obtain a line graph of adrenaline changes of the monitored person;

[0058] Construct a two-dimensional rectangular coordinate system of the content of endocrine hormones in the body of the monitored person in time, map the acquired content of endocrine hormones in the body of the monitored person to the constructed two-dimensional rectangular coordinate system of the content of endocrine hormones in the body of the monitored person in time, generate corresponding endocrine hormone data sample points, label the generated endocrine hormone data sample points as i, and connect each endocrine hormone data sample point in time order through a broken line to obtain a line graph of endocrine hormone changes of the monitored person.

[0059] The data analysis module is used to analyze the obtained thyroid hormone change line graph, adrenaline change line graph and endocrine hormone change line graph to obtain analysis results;

[0060] It should be further explained that, in the specific implementation process, the process of the data analysis module analyzing the obtained thyroid hormone change line graph, adrenaline change line graph and endocrine hormone change line graph includes:

[0061] Obtain the content of thyroid hormone in the body of the monitored person corresponding to each thyroid hormone data sample point, and set the thyroid hormone content threshold range according to the actual situation. If the content of thyroid hormone in the body of the monitored person corresponding to a thyroid hormone data sample point is not within the set thyroid hormone content threshold range, the content of thyroid hormone in the body of the monitored person is abnormal. If the content of thyroid hormone in the body of the monitored person corresponding to each thyroid hormone data sample point is within the set thyroid hormone content threshold range, the content of thyroid hormone in the body of the monitored person is normal, and the previous thyroid hormone data sample point of the last thyroid hormone data sample point is recorded as the reference thyroid hormone data sample point, and the content of thyroid hormone in the body of the monitored person corresponding to the last thyroid hormone data sample point is compared with the content of thyroid hormone in the body of the monitored person corresponding to the reference thyroid hormone data sample point;

[0062] If the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point is greater than or equal to the thyroid hormone content in the body of the monitored person corresponding to the reference thyroid hormone data sample point, the high prediction coefficient of the last thyroid hormone data sample point is obtained, and the high prediction coefficient of the last thyroid hormone data sample point obtained is recorded as Y 高 , when the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point is equal to the thyroid hormone content in the body of the monitored person corresponding to the reference thyroid hormone data sample point, the high prediction coefficient of the last thyroid hormone data sample point is recorded as "0", that is, Y 高 =0;

[0063] When the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point is greater than the thyroid hormone content in the body of the monitored person corresponding to the reference thyroid hormone data sample point, draw a straight line parallel to the horizontal axis through the reference thyroid hormone data sample point, draw a straight line parallel to the vertical axis through the last thyroid hormone data sample point, obtain the intersection of the two straight lines, obtain the area of ​​the right triangle formed by the last thyroid hormone data sample point, the reference thyroid hormone data sample point and the intersection of the two straight lines, and obtain the length of the hypotenuse of the right triangle;

[0064] It should be further explained that, in a specific implementation process, the process of obtaining the area and the length of the hypotenuse of the right triangle formed by the last thyroid hormone data sample point, the reference thyroid hormone data sample point, and the intersection of the two straight lines includes:

[0065] The thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point and the reference thyroid hormone data sample point is recorded as J 最 and J 参 ;

[0066] The time corresponding to the last thyroid hormone data sample point and the reference thyroid hormone data sample point is obtained, and the time corresponding to the last thyroid hormone data sample point and the reference thyroid hormone data sample point is recorded as t 最 and t 参 ;

[0067] According to the thyroid hormone content and time in the body of the monitored person corresponding to the last thyroid hormone data sample point and the reference thyroid hormone data sample point, the area of ​​the right triangle and the length of the hypotenuse are obtained, and the area of ​​the right triangle obtained is recorded as S 高 ;

[0068] in, ;

[0069] The length of the hypotenuse of the right triangle obtained is recorded as L 高 ;

[0070] in, ;

[0071] According to the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point obtained and the area and hypotenuse length of the obtained right triangle, a high prediction coefficient of the last thyroid hormone data sample point is obtained;

[0072] Right now ; kp_y is the adjustment coefficient;

[0073] If the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point is less than the thyroid hormone content in the body of the monitored person corresponding to the reference thyroid hormone data sample point, the low prediction coefficient of the last thyroid hormone data sample point is obtained, and the low prediction coefficient of the last thyroid hormone data sample point obtained is recorded as Y 低 ;

[0074] Draw a straight line parallel to the vertical axis through the reference thyroid hormone data sample point, draw a straight line parallel to the horizontal axis through the last thyroid hormone data sample point, obtain the intersection of the two straight lines, and use the same method to obtain the area and hypotenuse length of the right triangle formed by the last thyroid hormone data sample point, the reference thyroid hormone data sample point, and the intersection of the two straight lines;

[0075] The area and length of the hypotenuse of the obtained right triangle are recorded as S 低 and L 低 ;

[0076] According to the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point obtained and the area and hypotenuse length of the obtained right triangle, a low prediction coefficient of the last thyroid hormone data sample point is obtained;

[0077] Right now ; kp_d is the adjustment coefficient;

[0078] When the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point is greater than or equal to the thyroid hormone content in the body of the monitored person corresponding to the reference thyroid hormone data sample point, the thyroid hormone content in the body of the monitored person is predicted based on the high prediction coefficient of the last thyroid hormone data sample point obtained, and the risk level of the thyroid hormone content in the body of the monitored person that is not within the set thyroid hormone content threshold range is obtained;

[0079] A high prediction coefficient threshold is set according to actual conditions, and the set high prediction coefficient threshold is recorded as Y0;

[0080] When Y 高 When Y0 is less than 0, the risk level of the thyroid hormone content in the monitored person's body is not within the set thyroid hormone content threshold range, which is a level 1 risk;

[0081] When Y 高 When ≥Y0, the risk level of the thyroid hormone content in the monitored person's body is not within the set thyroid hormone content threshold range is level 2 risk;

[0082] It should be further explained that the secondary risk is higher than the primary risk;

[0083] When the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point is lower than the thyroid hormone content in the body of the monitored person corresponding to the reference thyroid hormone data sample point, the thyroid hormone content in the body of the monitored person is predicted based on the low prediction coefficient of the last thyroid hormone data sample point obtained, and the risk level of the thyroid hormone content in the body of the monitored person not being within the set thyroid hormone content threshold range is obtained;

[0084] A high prediction coefficient threshold is set according to actual conditions, and the set high prediction coefficient threshold is recorded as Y1;

[0085] When Y 低 When the thyroid hormone content in the monitored person's body is less than Y1, the risk level is level 1 if the thyroid hormone content in the monitored person is not within the set thyroid hormone content threshold range;

[0086] When Y 低 When ≥Y1, the risk level of the thyroid hormone content in the monitored person's body is not within the set thyroid hormone content threshold range is level 2 risk;

[0087] The adrenaline content in the body of the monitored person corresponding to each adrenaline data sample point is obtained, and the adrenaline content threshold range is set according to the actual situation. If the adrenaline content in the body of the monitored person corresponding to the adrenaline data sample point is not within the set adrenaline content threshold range, the adrenaline content in the body of the monitored person is abnormal. If the adrenaline content in the body of the monitored person corresponding to each adrenaline data sample point is within the set adrenaline content threshold range, the adrenaline content in the body of the monitored person is normal. The same method is used to obtain the risk level of the adrenaline content in the body of the monitored person that is not within the set adrenaline content threshold range, and the risk level includes a primary risk and a secondary risk;

[0088] The endocrine hormone content in the body of the monitored person corresponding to each endocrine hormone data sample point is obtained, and the endocrine hormone content threshold range is set according to the actual situation. If the endocrine hormone content in the body of the monitored person corresponding to the endocrine hormone data sample point is not within the set endocrine hormone content threshold range, the endocrine hormone content in the body of the monitored person is abnormal. If the endocrine hormone content in the body of the monitored person corresponding to each endocrine hormone data sample point is within the set endocrine hormone content threshold range, the endocrine hormone content in the body of the monitored person is normal. The same method is used to obtain the risk level of the endocrine hormone content in the body of the monitored person that is not within the set endocrine hormone content threshold range, and the risk level includes primary risk and secondary risk.

[0089] The health assessment module is used to assess whether the endocrine system of the monitored person is healthy based on the analysis results to obtain the assessment results;

[0090] It should be further explained that, in the specific implementation process, the process of the health assessment module assessing whether the endocrine of the monitored person is healthy according to the analysis results includes:

[0091] When the levels of thyroid hormone, adrenaline and endocrine hormones in the monitored person's body are normal, the monitored person's endocrine system is healthy;

[0092] When the content of thyroid hormone, adrenaline or endocrine hormone in the body of the monitored person is abnormal, the endocrine of the monitored person is unhealthy;

[0093] When the thyroid hormone content in the monitored person's body is not within the set thyroid hormone content threshold range and the risk level is Level 2 risk, or the adrenaline content is not within the set adrenaline content threshold range and the risk level is Level 2 risk, or the endocrine hormone content is not within the set endocrine hormone content threshold range and the risk level is Level 2 risk, the monitored person's endocrine prediction is unhealthy.

[0094] The prevention and treatment module is used to carry out prevention and treatment on the monitored person according to the evaluation results;

[0095] It should be further explained that, in the specific implementation process, the prevention and treatment module performs prevention and treatment on the monitored person according to the evaluation results, including:

[0096] When the endocrine system of the monitored person is unhealthy, the corresponding symptoms and corresponding medicines are obtained according to the endocrine medical atlas, and the monitored person is treated with the obtained corresponding medicines;

[0097] When the endocrine prediction of the monitored person is unhealthy, the monitored person will be reminded to take corresponding preventive measures.

[0098] The above embodiments are only used to illustrate the technical method of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical method of the present invention may be modified or replaced by equivalents without departing from the spirit and scope of the technical method of the present invention.

Claims

1. An endocrine health monitoring system based on medical atlas, comprising a monitoring center, It is characterized in that The monitoring center is communicatively connected to a data acquisition module, a medical atlas construction module, a data processing module, a data analysis module, a health assessment module, and a prevention and treatment module; The data acquisition module is used to collect physical data of the monitored person; The medical atlas construction module is used to construct an endocrine medical atlas based on the collected physical data of the monitored person; The data processing module is used to process the physical data of the monitored person in the constructed endocrine medical atlas to obtain a thyroid hormone change line graph, an adrenaline change line graph, and an endocrine hormone change line graph; Constructing a two-dimensional rectangular coordinate system of the thyroid hormone content in the body of the monitored person in terms of time, mapping the acquired thyroid hormone content in the body of the monitored person to the constructed two-dimensional rectangular coordinate system of the thyroid hormone content in the body of the monitored person in terms of time, generating corresponding thyroid hormone data sample points, and connecting each thyroid hormone data sample point in sequence through a broken line in chronological order to obtain a broken line graph of thyroid hormone changes in the monitored person; Constructing a two-dimensional rectangular coordinate system of the adrenaline content in the body of the monitored person in terms of time, mapping the acquired adrenaline content in the body of the monitored person to the constructed two-dimensional rectangular coordinate system of the adrenaline content in the body of the monitored person in terms of time, generating corresponding adrenaline data sample points, and connecting each adrenaline data sample point in time sequence through a broken line to obtain a broken line graph of adrenaline changes in the monitored person; Constructing a two-dimensional rectangular coordinate system of the content of endocrine hormones in the body of the monitored person in terms of time, mapping the obtained content of endocrine hormones in the body of the monitored person to the constructed two-dimensional rectangular coordinate system of the content of endocrine hormones in the body of the monitored person in terms of time, generating corresponding endocrine hormone data sample points, and connecting each endocrine hormone data sample point in time order through a broken line to obtain a broken line graph of endocrine hormone changes in the monitored person; The data analysis module is used to analyze the obtained thyroid hormone change line graph, adrenaline change line graph and endocrine hormone change line graph to obtain analysis results; Obtain the thyroid hormone content in the body of the monitored person corresponding to each thyroid hormone data sample point, and set the thyroid hormone content threshold range according to the actual situation. If the thyroid hormone content in the body of the monitored person corresponding to a thyroid hormone data sample point is not within the set thyroid hormone content threshold range, the thyroid hormone content in the body of the monitored person is abnormal; otherwise, the thyroid hormone content in the body of the monitored person is normal, and the previous thyroid hormone data sample point of the last thyroid hormone data sample point is recorded as the reference thyroid hormone data sample point, and the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point is compared with the thyroid hormone content in the body of the monitored person corresponding to the reference thyroid hormone data sample point; Obtaining a high prediction coefficient or a low prediction coefficient of the last thyroid hormone data sample point according to the comparison result; The thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point and the reference thyroid hormone data sample point is recorded as J 最 and J 参 ; The time corresponding to the last thyroid hormone data sample point and the reference thyroid hormone data sample point is obtained, and the time corresponding to the last thyroid hormone data sample point and the reference thyroid hormone data sample point is recorded as t 最 and t 参 ; If the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point is greater than or equal to the thyroid hormone content in the body of the monitored person corresponding to the reference thyroid hormone data sample point, then the high prediction coefficient Y of the last thyroid hormone data sample point is obtained. 高 ; According to the thyroid hormone content and time in the body of the monitored person corresponding to the last thyroid hormone data sample point and the reference thyroid hormone data sample point, the area of ​​the right triangle and the length of the hypotenuse are obtained, and the area of ​​the right triangle obtained is recorded as S 高 ; The length of the hypotenuse of the right triangle obtained is recorded as L 高 ; According to the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point obtained and the area and hypotenuse length of the obtained right triangle, a high prediction coefficient of the last thyroid hormone data sample point is obtained; Right now ; kp_y is the adjustment coefficient; If the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point is less than the thyroid hormone content in the body of the monitored person corresponding to the reference thyroid hormone data sample point, the low prediction coefficient of the last thyroid hormone data sample point is obtained, and the low prediction coefficient of the last thyroid hormone data sample point obtained is recorded as Y 低 ; Draw a straight line parallel to the vertical axis through the reference thyroid hormone data sample point, draw a straight line parallel to the horizontal axis through the last thyroid hormone data sample point, obtain the intersection of the two straight lines, and use the same method to obtain the area and hypotenuse length of the right triangle formed by the last thyroid hormone data sample point, the reference thyroid hormone data sample point, and the intersection of the two straight lines; The area and length of the hypotenuse of the obtained right triangle are respectively recorded as S 低 and L 低 ; According to the thyroid hormone content in the body of the monitored person corresponding to the last thyroid hormone data sample point obtained and the area and hypotenuse length of the obtained right triangle, a low prediction coefficient of the last thyroid hormone data sample point is obtained; Right now ; kp_d is the adjustment coefficient; Predicting the thyroid hormone content in the body of the monitored person according to the obtained high prediction coefficient and low prediction coefficient, and obtaining a risk level if the thyroid hormone content in the body of the monitored person is not within the set thyroid hormone content threshold range, wherein the risk level includes a primary risk and a secondary risk; The adrenaline content in the body of the monitored person corresponding to each adrenaline data sample point is obtained, and the adrenaline content threshold range is set according to the actual situation. If the adrenaline content in the body of the monitored person corresponding to the adrenaline data sample point is not within the set adrenaline content threshold range, the adrenaline content in the body of the monitored person is abnormal. Otherwise, the adrenaline content in the body of the monitored person is normal. The same method is used to obtain the risk level of the adrenaline content in the body of the monitored person that is not within the set adrenaline content threshold range. The risk level includes primary risk and secondary risk; Obtain the endocrine hormone content in the body of the monitored person corresponding to each endocrine hormone data sample point, and set the endocrine hormone content threshold range according to the actual situation. If the endocrine hormone content in the body of the monitored person corresponding to the endocrine hormone data sample point is not within the set endocrine hormone content threshold range, the endocrine hormone content in the body of the monitored person is abnormal. Otherwise, the endocrine hormone content in the body of the monitored person is normal. The same method is used to obtain the risk level of the endocrine hormone content in the body of the monitored person that is not within the set endocrine hormone content threshold range. The risk level includes primary risk and secondary risk. The health assessment module is used to assess whether the endocrine system of the monitored person is healthy based on the analysis results to obtain an assessment result; The prevention and treatment module is used to carry out prevention and treatment on the monitored person according to the evaluation results.

2. The endocrine health monitoring system based on medical atlas according to claim 1, It is characterized in that The process of the data collection module collecting the physical data of the monitored person includes: The physical data of the monitored person includes the content of thyroid hormone, adrenaline and endocrine hormone in the body of the monitored person; The data acquisition module is provided with a hormone data acquisition terminal, and the hormone data acquisition terminal is used to collect the content of thyroid hormone, adrenaline and endocrine hormone in the body of the monitored person; The hormone data collection terminal is used to obtain the thyroid hormone content, adrenaline content and endocrine hormone content in the body of the monitored person.

3. The endocrine health monitoring system based on medical atlas according to claim 2, It is characterized in that The process of the medical atlas construction module constructing an endocrine medical atlas according to the collected physical data of the monitored person includes: The endocrine medical atlas is composed of a thyroid hormone node, an adrenaline node, an endocrine hormone node, a thyroid hormone symptom node, an adrenaline symptom node, an endocrine hormone symptom node, a thyroid hormone drug node, an adrenaline drug node, and an endocrine hormone drug node; Connect the corresponding nodes, obtain the symptoms and corresponding drugs caused by the content of thyroid hormone, adrenaline and endocrine hormone according to the medical data in the hospital, input the obtained symptoms caused by the content of thyroid hormone into the thyroid hormone symptom node, input the obtained drugs corresponding to the symptoms caused by the content of thyroid hormone into the thyroid hormone drug node, and so on, input the corresponding symptoms and drugs into the corresponding nodes; The obtained thyroid hormone content, adrenaline content and endocrine hormone content in the body of the monitored person are input into the thyroid hormone node, adrenaline node and endocrine hormone node respectively.

4. The endocrine health monitoring system based on medical atlas according to claim 3, It is characterized in that The process of the health assessment module assessing whether the endocrine system of the monitored person is healthy according to the analysis results includes: When the levels of thyroid hormone, adrenaline and endocrine hormones in the monitored person's body are normal, the monitored person's endocrine system is healthy; When the content of thyroid hormone, adrenaline or endocrine hormone in the body of the monitored person is abnormal, the endocrine of the monitored person is unhealthy; When the thyroid hormone content in the monitored person's body is not within the set thyroid hormone content threshold range and the risk level is Level 2 risk, or the adrenaline content is not within the set adrenaline content threshold range and the risk level is Level 2 risk, or the endocrine hormone content is not within the set endocrine hormone content threshold range and the risk level is Level 2 risk, the monitored person's endocrine prediction is unhealthy.

5. The endocrine health monitoring system based on medical atlas according to claim 4, It is characterized in that The process of the prevention and treatment module performing prevention and treatment on the monitored person according to the evaluation results includes: When the endocrine system of the monitored person is unhealthy, the corresponding symptoms and corresponding medicines are obtained according to the endocrine medical atlas, and the monitored person is treated with the obtained corresponding medicines; When the endocrine prediction of the monitored person is unhealthy, the monitored person will be reminded to take corresponding preventive measures.

Images